1. What 2 neurotransmitters are thought to be involved in the pathophysiology of attention-deficit/hyperactivity disorder (ADHD)?
A. Dopamine and Norepinephrine
B. Dopamine and Serotonin
C. Dopamine and Glutamate
D. Dopamine and GABA
2. Which of the following is a risk factor for developing ADHD:
A. Consuming foods high in additives
B. Consuming foods high in sugar
C. Family history of ADHD
D. High birth weight
3. Which of the following patients would meet criteria for at least of 1 ADHD subtype based on the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5 criteria):
A. A girl, 9 years of age, who has had 5 symptoms of inattentiveness consecutively for 6 months at home and at school
B. An boy, 8 years of age, who has had 5 symptoms of hyperactivity/impulsivity consecutively for 5 months at home and at school
C. A girl, 12 years of age, who has had 6 symptoms of hyperactivity/impulsivity consecutively for 6 months at home only
D. A boy, 11 years of age, who has had 6 symptoms of inattentiveness consecutively for 6 months at home and at school
4. According to the guidelines discussed, which of the following is the proper initial treatment for girl, 4 years of age, with ADHD:
A. Stimulant
B. Alpha-adrenergic agent
C. Teacher-administered behavior therapy
D. Habit reversal therapy
5. Which of the following is a recommended nonpharmacologic option for the treatment of ADHD:
A. Elimination of artificial coloring
B. Behavioral interventions
C. Avoidance of exercise
D. Supplementation with fatty acids
6. Which of the following side effect is most common during stimulant treatment:
A. Sedation
B. Anorexia
C. Hypertension
D. Elevated liver function tests
7. Which one of the following stimulants is indicated to be administered once daily:
A. Methylphenidate IR
B. Methylphenidate ER
C. Mixed amphetamine salts ER
D. OROS methylphenidate
8. Which of the following stimulants have a U.S. Food and Drug Administration (FDA)-approved indication for ADHD for a child as young as 3 years of age:
A. Lisdexamfetamine
B. Methylphenidate extended-release (OROS MPH)
C. Amphetamine sulfate IR
D. Dexmethylphenidate ER
9. Which of the following is a common side effect of Clonidine ER:
A. Tachycardia
B. Insomnia
C. Atrial fibrillation
D. Orthostatic hypotension
10. Which one of the following nonstimulant medications does not have an FDA-approved indication for the treatment of ADHD:
A. Atomoxetine
B. Clonidine ER
C. Guanfacine IR
D. Guanfacine ER
11. Which medication is recommended if there is a concern regarding misuse of prescription stimulants?
A. Lisdexamfetamine
B. Methylphenidate IR
C. Mixed amphetamine salts XR
D. Dexmethylphenidate
Evaluation Questions
12. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. To what extent did the program meet objective #6?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
24. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
25. Will the information presented cause you to change your practice?
A. Yes
B. No
26. Are you committed to making these changes?
A. Yes
B. No
27. As a result of this activity, did you learn something new?
A. Yes
B. No
28. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology/Specialty Pharmacy
I. Industry/Manufacturing
29. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
